Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception

This study has been completed.
Information provided by:
HRA Pharma Identifier:
First received: October 30, 2007
Last updated: June 16, 2010
Last verified: June 2010